Peak Flow Monitoring in Respiratory Disease Management

Introduction to Peak Flow Monitoring

The American Thoracic Society recommends peak expiratory flow (PEF) monitoring as a practical alternative to spirometry for short-term management and monitoring of already-diagnosed patients, but not for initial diagnosis of COPD or asthma 1

Spirometry remains essential and irreplaceable for confirming the diagnosis of COPD, which requires demonstration of post-bronchodilator FEV1/FVC <0.7, as recommended by the European Respiratory Society 1, 2
PEF cannot differentiate between obstructive and restrictive patterns or provide the detailed information needed for proper disease classification, according to the American College of Chest Physicians 1

Serial PEF recordings over one week can help assess variability and support day-to-day management of patients already diagnosed with COPD, as suggested by the British Thoracic Society 1
All patients with suspected obstructive disease based on PEF must have confirmatory spirometry performed as soon as possible, as recommended by the National Institute for Health and Care Excellence 1, 2

Arterial oxygen saturation via pulse oximetry can be used to indicate the need for arterial blood gas measurement in moderate COPD, according to the European Respiratory Society 3
Chest radiograph can exclude other pathologies but cannot positively diagnose COPD, as stated by the American College of Radiology 1
Exercise testing (6-minute walk) can be used for patients with breathlessness disproportionate to symptoms, although reproducibility is poor, as noted by the European Respiratory Society 3

The American College of Physicians recommends that peak flow monitoring should not be used for long-term disease monitoring or severity staging, as it provides insufficient information 1
The European Respiratory Society advises against diagnosing COPD based on PEF alone, as this leads to significant misdiagnosis rates 4